RBC trims Abbott’s target, still likes the stock

Same story, slightly smaller upside

Abbott got a fresh round of Wall Street scrutiny, and RBC shaved its price target to $130 from $135 while keeping an Outperform rating. Translation: the bank didn’t toss Abbott into the penalty box — it just moved the finish line a few feet closer.

Why you should care

Price-target cuts can be annoying because they often show up right when a stock is already wobbling. Abbott’s latest analyst chatter is part of a bigger rethink on the name, with multiple firms tweaking targets after the company’s recent update. When the target comes down, the message is usually: the stock still has a case, but maybe not as much runway as before.

The investor takeaway

For you, this is less "something broke" and more "the math got a haircut." Keeping an Outperform rating matters because it signals RBC still sees upside versus the market, even if the path there looks a bit less dramatic.

Big picture: Abbott is still getting the benefit of the doubt — just with a slightly smaller victory lap.